Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Novartis India Limited
  6. News
  7. Summary
    500672   INE234A01025

NOVARTIS INDIA LIMITED

(500672)
  Report
End-of-day quote. End-of-day quote Bombay Stock Exchange - 09/20
811.45 INR   -2.97%
08/17NOVARTIS INDIA LIMITED : Ex-dividend day for final dividend
FA
08/12NOVARTIS INDIA : Net Profit Climbs in Fiscal Q1
MT
08/11Indian Indices End at Mixed Note on Wednesday; Tata Steel Jumps 4%
MT
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CureVac and Novartis Sign Initial Agreement on Manufacturing of COVID-19 Vaccine Candidate, CVnCoV

03/04/2021 | 07:00am EDT

CureVac N.V. and Novartis AG announced that they have signed an initial agreement for the manufacturing of CureVac's COVID-19 vaccine candidate, CVnCoV. Preparations for the start of production, technology transfers and test runs are already underway. Following final agreement, Novartis plans to manufacture the mRNA and bulk drug product of the CVnCoV vaccine candidate for up to 50 million doses by the end of 2021 and up to a further 200 million doses in 2022. Delivery from the manufacturing site in Kundl, Austria, is expected to start in summer 2021.


ę S&P Capital IQ 2021
All news about NOVARTIS INDIA LIMITED
08/17NOVARTIS INDIA LIMITED : Ex-dividend day for final dividend
FA
08/12NOVARTIS INDIA : Net Profit Climbs in Fiscal Q1
MT
08/11Indian Indices End at Mixed Note on Wednesday; Tata Steel Jumps 4%
MT
08/11Novartis India Limited Announces Earnings Results for the First Quarter Ended..
CI
06/17NOVARTIS INDIA : Consolidated Net Profit Climbs in Fiscal Q4
MT
06/17Novartis India Limited Reports Earnings Results for the Fourth Quarter Ended ..
CI
06/17Novartis India Limited Recommends Final Dividend for the Year Ended March 31,..
CI
03/23NOVARTIS INDIA : inaugurates innovative watershed project in India to increase w..
AQ
03/04CureVac and Novartis Sign Initial Agreement on Manufacturing of COVID-19 Vacc..
CI
02/11Novartis India Limited Reports Earnings Results for the Third Quarter Ended D..
CI
More news
Financials
Sales 2021 3 814 M 51,8 M 51,8 M
Net income 2021 209 M 2,84 M 2,84 M
Net cash 2021 4 349 M 59,1 M 59,1 M
P/E ratio 2021 65,2x
Yield 2021 1,81%
Capitalization 20 035 M 272 M 272 M
EV / Sales 2020 1,66x
EV / Sales 2021 2,43x
Nbr of Employees 539
Free-Float 27,3%
Chart NOVARTIS INDIA LIMITED
Duration : Period :
Novartis India Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVARTIS INDIA LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Managers and Directors
Sanjay Prabhakar Murdeshwar Vice Chairman & Managing Director
Felix Doss Chief Financial Officer
Christopher Snook Non-Executive Chairman
Trivikram Guda Secretary & Compliance Officer
Jai Vishwanath Hiremath Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
NOVARTIS INDIA LIMITED18.43%272
JOHNSON & JOHNSON4.09%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY37.20%208 604